“Breakthrough Drug” for Hepatitis C Within Reach
Wednesday, January 1, 2014
On December 6, 2013, the Food and Drug Administration (FDA) approved the eagerly awaited Hepatitis C medication sofosbuvir (Sovaldi™, Gilead Sciences, Inc.) and gave it the designation of “breakthrough therapy”. An…